Vitasora Health Limited
Vitasora Health Limited
Your view on VHL.AX
Overview
What the company does, where it operates, and who runs it.
About Vitasora Health Limited
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Marjan Mikel
- Headquarters
- 432 St Kilda Road, Melbourne, VIC, AU
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Marjan Mikel
- Headquarters
- 432 St Kilda Road, Melbourne, VIC, AU
Headquartered in Melbourne, Australia, Vitasora Health Limited specializes in the research, development, and market introduction of medical devices across Australia and the United States. The company's portfolio also includes the creation of mobile health applications.
Notably, the firm, previously known as Respiri Limited, officially rebranded as Vitasora Health Limited in April 2025.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Vitasora Health Limited. Starting points for Vitasora Health Limited: EPS -AUD 0.0068, beta -0.37 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Vitasora Health Limited. Vitasora Health Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Vitasora Health Limited. Trailing twelve-month EPS for Vitasora Health Limited stands at -AUD 0.0068. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterJun 2025 | Next quarterDec 2025 | This yearYear to Jun 2025 | Next yearYear to Jun 2026 |
|---|---|---|---|---|
| Average estimate | −AUD 0.00 | AUD 0.00 | −AUD 0.01 | −AUD 0.01 |
| Lowest estimate | −AUD 0.00 | AUD 0.00 | −AUD 0.01 | −AUD 0.01 |
| Highest estimate | −AUD 0.00 | AUD 0.00 | −AUD 0.01 | −AUD 0.01 |
| Number of analysts | 1 | 0 | 1 | 1 |
| A year ago | — | — | −AUD 0.011 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterJun 2025 | Next quarterDec 2025 | This yearYear to Jun 2025 | Next yearYear to Jun 2026 |
|---|---|---|---|---|
| Average estimate | AUD 4.00M | AUD 18.00M | AUD 4.90M | AUD 6.30M |
| Lowest estimate | AUD 4.00M | AUD 18.00M | AUD 4.90M | AUD 6.30M |
| Highest estimate | AUD 4.00M | AUD 18.00M | AUD 4.90M | AUD 6.30M |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | AUD 456914.00 | — |
| Growth vs a year ago | — | — | +972.4% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Vitasora Health Limited. Vitasora Health Limited has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| MDNWFMednow Inc. | Healthcare | OTC | $517,288 | ||
| MDRXVeradigm Inc. | Healthcare | OTC | $730.3M | ||
| MDXLMediXall Group, Inc. | Healthcare | OTC | $20,551 | ||
| MGRXMangoceuticals, Inc. | Healthcare | NASDAQ | $3.3M | ||
| MRDHMeridian Holdings, Inc. | Healthcare | OTC | $172,780 | ||
| MSPRMSP Recovery, Inc. | Healthcare | NASDAQ | $1,377 | ||
| MTHRFM3, Inc. | Healthcare | OTC | $7.7B | ||
| MTHRYM3, Inc. | Healthcare | OTC | $6.7B | ||
| NARA.CNPangenomic Health Inc. | Healthcare | CNQ | $7.0M | ||
| NDATFnDatalyze Corp. | Healthcare | OTC | $826,549 | ||
| NEGXFNexgenRx Inc. | Healthcare | OTC | $19.9M | ||
| NEWUFNewtopia Inc. | Healthcare | OTC | $86,633 | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Vitasora Health Limited.